Latest News about REGN
Recent news which mentions REGN
Dupixent Becomes First Biologic To Show Benefit In Infant Patients With Atopic Dermatitis
August 30, 2021
From Benzinga
7 Best ETFs to Buy to Cover a Broad Spectrum of Opportunities
August 27, 2021
From InvestorPlace
From Motley Fool
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
From Benzinga
3 Growth Stocks Near Record Highs That Are Still Worth Buying
August 27, 2021
From Motley Fool
Regeneron Touts Mid-Stage Win For Higher Dose Of Eylea In Age-related Macular Degeneration
August 24, 2021
From Benzinga
From Benzinga
4 Reasons I Just Bought Ocular Therapeutix Stock
August 21, 2021
From Motley Fool
Stocks That Hit 52-Week Highs On Friday
August 20, 2021
From Benzinga
UK Approves Regeneron - Roche's COVID-19 Antibody Cocktail
August 20, 2021
From Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
From Benzinga
The reflation trade is fading. Here’s what to avoid, and where to seek refuge, in commodities.
August 20, 2021
From MarketWatch
U.S. prepares to administer 100 million booster shots as Biden tells Americans it will ‘help us end the pandemic faster’
August 19, 2021
From MarketWatch
From Benzinga
PreMarket Prep Stock Of The Day: Regeneron
August 18, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
August 18, 2021
From Benzinga
5 Stocks Insiders Are Selling
August 18, 2021
From Benzinga
From Benzinga
JD.com And Tesla Lead The Nasdaq Lower Tuesday
August 17, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
August 17, 2021
From Benzinga
From Benzinga
From Motley Fool
Regeneron's Antibody Cocktail Authorized for Preventing COVID: Why It's Not a Big Deal for the Stock
August 14, 2021
Tickers
REGN
From Motley Fool
eBay And AMD Lead The QQQ Friday
August 13, 2021
From Benzinga
What Rinvoq's Positive News Means for AbbVie
August 13, 2021
From Motley Fool
FDA expected to authorize an extra COVID-19 dose for people with weak immune systems in the first regulatory OK for a booster shot in the U.S.
August 12, 2021
From MarketWatch
Will Moderna Buy Editas Medicine to Jump Into Gene Editing?
August 12, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.